Skip to content
healthcare.dev

Cisatracurium Besylate

NDC 71288-713, Cisatracurium Besylate, injection, solution, from Meitheal Pharmaceuticals Inc..

Product NDC
71288-713
Status
Listed
Labeler
Meitheal Pharmaceuticals Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211668
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71288-713 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CISATRACURIUM BESYLATE200 mg/20mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
71288-713-217128807132110 VIAL, SINGLE-DOSE in 1 CARTON (71288-713-21) / 20 mL in 1 VIAL, SINGLE-DOSE (71288-713-20)
71288-713-967128807139610 VIAL, SINGLE-DOSE in 1 CARTON (71288-713-96) / 20 mL in 1 VIAL, SINGLE-DOSE (71288-713-95)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels?ndc=71288-713

Use it

Look up 71288-713 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71288-713 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71288-713. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.